Gestational Diabetes Market to Grow at a CAGR of 8.8% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Gestational Diabetes Market?

The gestational diabetes market has seen substantial growth recently. It is projected to increase from $8.37 billion in 2024 to $9.11 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.9%. This past growth can be attributed to factors such as an elevated risk of diabetes, enhanced accuracy in measuring blood glucose levels, a rise in the number of insurance providers, and an expanding population of diabetic patients.

The gestational diabetes market is anticipated to show strong expansion in the coming years, projected to reach $12.78 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period is attributed to factors such as an increase in obesity rates, the growing acceptance of cloud-based project arrangements, the expanding utilization of related devices and applications, the increasing prevalence of diabetes due to unhealthy lifestyles, a rise in public health consciousness, and escalating diabetes prevalence rates. Prominent trends for this period include digital diabetes management apps, closed-loop control systems, advancements in diabetes management technology, enzymatic technology, and innovative medical technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp

What Are The Key Drivers Of Growth In The Gestational Diabetes Market?

The expanding obese population is projected to stimulate the growth of the gestational diabetes market moving forward. The obese population refers to individuals with a body mass index (BMI) of 30 or greater, signifying an excess of body fat that can present considerable health dangers. This population is growing as a result of a mix of inactive lifestyles, greater intake of high-calorie, processed foods, genetic factors, and restricted availability of nutritious food and exercise alternatives. Addressing gestational diabetes is vital for the obese population because their elevated likelihood of insulin resistance and substantial weight gain during pregnancy can cause health issues for both the mother and infant if not managed. For instance, in March 2024, data from the World Health Organization, a Switzerland-based intergovernmental organization, indicated that around 1 in 8 people worldwide were affected by obesity in 2022, with 2.5 billion adults aged 18 and older categorized as overweight, a figure that includes 890 million individuals living with obesity. Among adults, 43% were overweight, and 16% were living with obesity. Furthermore, 37 million children under the age of 5 were overweight, while more than 390 million children and adolescents aged 5–19 years were overweight, with 160 million of those living with obesity. Consequently, the rising obese population is propelling the gestational diabetes market.

How Is The Gestational Diabetes Market Classified Into Different Segments?

The gestational diabetesmarket covered in this report is segmented –

1) By Types: Type A1; Type A2; Other Types

2) By Treatment: Monitoring; Drug Treatment; Non-pharmacological treatment

3) By Administration: Oral; Intravenous; Other Administrations

4) By End User: Hospitals; Clinics; Home Care Settings; Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes; Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes; Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes; Gestational Diabetes With Complications

Which Ongoing Trends Are Expected To Shape The Gestational Diabetes Market Outlook?

Leading companies in the gestational diabetes market are concentrating on developing sophisticated technological products, such as diagnostic kits specifically for gestational diabetes, to offer quick, accurate, and convenient solutions for early identification. A diagnostic kit for gestational diabetes functions as a medical device that measures blood glucose levels and detects abnormal glucose tolerance in pregnant women, thereby supporting the condition’s early detection and ongoing management. For example, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, unveiled the XpressGT RUO kit, a diagnostic kit engineered to diagnose gestational diabetes, endometriosis, insulin resistance, and liver disease. It precisely measures 2-hydroxybutyrate (2-HB) levels found in venous blood, which is naturally produced by the liver during its regular functions. Elevated 2-HB levels are linked to increased reductive stress, a factor associated with various endocrine and obesity-related disorders, including insulin resistance. The kit is compatible with any existing clinical analyzer and yields results in merely 8 minutes, presenting a swift and effective diagnostic solution.

Who Are The Primary Competitors In The Global Gestational Diabetes Market?

Major companies operating in the gestational diabetes market are Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Dexcom Inc, Biocon Limited, LifeScan Inc, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Nipro Diagnostics, Inc., Sernova Corp., ZyVersa Therapeutics, Inc., Peptron Inc., Roche Diabetes Care, DiabetOmics Inc, Merck & Co. Inc., Medtronic plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

What Are The Key Regional Factors Influencing The Gestational Diabetes Market Growth?

North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gestational Diabetes Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20818&type=smp

Browse Through More Reports Similar to the Global Gestational Diabetes Market 2025, By The Business Research Company

Diabetes Care Devices Market 2025

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Diabetes Therapies Market 2025

https://www.thebusinessresearchcompany.com/report/diabetes-therapies-market

Digital Diabetes Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795